Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction: A Call to Action

Published: July 11, 2022

Condition of high blood pressure in the arteries that go from your heart to your lungs
  • This scientific statement clarifies key knowledge gaps associated with pulmonary hypertension (PH) due to heart failure with preserved ejection fraction (HFpEF) and suggests specific scientific research priorities for addressing identified gaps.
  • The management of PH-HFpEF is challenging because of the lack of proven PH therapies in the setting of HFpEF.
  • This call to action encourages the scientific community to prioritize the study of PH-HFpEF, which requires collaboration, data sharing, and supportive clinical trial design.